Dr. Patrick Andrew Baghdasaryan, MD

Dr. Baghdasaryan practices at Saint Gregory Heart and Vascular Center, Inc. in Glendale, California.

Dr. Baghdasaryan's NPI, 1912448358, was assigned on March 18, 2017. Dr. Baghdasaryan graduated from St. George's University School of Medicine in 2017. Dr. Baghdasaryan holds California license A163370.

Dr. Baghdasaryan's primary practice is Saint Gregory Heart and Vascular Center, Inc., at 1560 E Chevy Chase Dr, Glendale, CA 91206 in Los Angeles County. The practice phone is (800) 626-2468.

Dr. Baghdasaryan's primary practice is Saint Gregory Heart and Vascular Center, Inc. in Glendale, California. Dr. Baghdasaryan is also affiliated with Adventist Health Glendale. The medical group on file is Saint Gregory Heart and Vascular Center. Dmand AI also links Dr. Baghdasaryan to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Baghdasaryan practices, 3 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Baghdasaryan's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Baghdasaryan is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Baghdasaryan is licensed in California.

CMS data shows 677 Medicare services from Dr. Baghdasaryan across 10 procedure codes in 2024, for 258 Medicare patients. Medicare paid $51,284 for them.

CMS counts 258 Medicare patients who saw Dr. Baghdasaryan in 2024. The largest group is 65 to 74, with 136 patients. 75% of them have arthritis, and 75% have high blood pressure. 89% are also on Medicaid. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Baghdasaryan's median patient age at 60, with 52% women.

In 2024, Dr. Baghdasaryan wrote 220 Medicare Part D claims for 96 patients. 75% of them were for generic drugs. CMS names the drug for 121 of them, across 6 drugs with 11 or more claims each, at $9,054 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Baghdasaryan for performance year 2024, reported as part of a group. Dr. Baghdasaryan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Baghdasaryan as offering telehealth. CMS counts 12 procedures of pacemaker insertion or repair by Dr. Baghdasaryan, more than 63% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Baghdasaryan, published from 2019 to 2022. 2021 was the busiest year, with 2. Dr. Baghdasaryan has published most often in Int J Angiol. Dr. Baghdasaryan's most frequent co-authors are Ramdas G. Pai, MD, Padmini Varadarajan, MD and Ashis Mukherjee, MD.

CMS Open Payments shows 100 general payments to Dr. Baghdasaryan from 28 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 97% of the total. Medtronic, Inc. paid the most, $449.

Dr. Baghdasaryan graduated from St. George's University School of Medicine in 2017.

Dr. Baghdasaryan is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.